GT20029 is discussed as a potential treatment for androgenetic hair loss by targeting androgenreceptors, unlike finasteride which reduces DHT broadly. Concerns include its effectiveness, geneticvariations in androgenreceptors, and availability, with some skepticism about its potential as a true alternative.
Hair loss theory suggests imbalance between Vitamin D Receptor (VDR) and AndrogenReceptor (AR) activation. Proposed treatment includes upregulating VDR, downregulating AR, and improving mitochondrial health.
Dutasteride works for most men, but some may experience worsening due to reasons like shedding, paranoia, non-androgenic alopecia, geneticvariations, or smoking. Smoking can increase scalp DHT levels and damage follicles.
The user is using testosterone and finasteride to prevent hair loss and is considering adding Primobolan or Masteron, which are DHT-derivatives. They are seeking advice on their genetic risk for male pattern baldness and whether they can safely use these compounds without significant hair loss.
The post and conversation are about the user's high testosterone levels and their worsening hair loss despite trying various treatments. They are considering using low doses of anti-androgens to lower their testosterone levels as a potential solution.